Car T therapy approved by FDA for adults with relapsed or refractory B-cell precursor acute lymphoblastic leukemia (ALL)
This information was current at the time of publishing.
The advancement of Car T therapy for the blood cancers is definitely something to keep watching. This quote from a October 4th Med Page Today article gives some hope to folks with ALL.
“Adults with ALL face a significantly poorer prognosis compared to children, and roughly half of all adults with B-ALL will relapse on currently available therapies,” said investigator Bijal Shah, MD, of the Moffitt Cancer Center in Tampa, Florida, in a press release from manufacturer Kite Pharma. “We now have a new meaningful advancement in treatment for these patients. A single infusion of Tecartus has demonstrated durable responses, suggesting the potential for long-term remission and a new approach to care.” See the entire article here:
Here is a video presentation and article about the specifics of the Zuma-3 clinical trial which lead to this approval.
Are clinical trials worth while? You bet! See these articles from bloodcanceruncensored.com:
Connect with us
We will keep you updated with more articles like this one
- Lisa Wiest
Blood cancer DX 1/5/17 (CLL). I am a nobody in the grand scheme. I can choose to be overwhelmed by my circumstances and all the "whys" and "what fors" or I can surrender. I choose surrender. By the grace of God through Jesus Christ, I have become a Child of God. Being on His team is the only sure thing in this life. This is my journey. A peek into my joys, fears, and passions. Come along with me and smell the flowers along the way. ~Lisa You can e-mail Lisa here.
- Market Research on Car T Therapy--a paid study for USA residents from Health Union June 14, 2023
- Paid Research Opportunity for UK residents on Social Isolation During the Covid-19 Pandemic April 2, 2023
- A New Survey From Our Partners at Health Union for USA Blood Cancer Patients March 23, 2023
- Remembering Tom Henry: Pharmacist, CLL Patient, Advocate, Spouse, Father, and Friend one year later February 9, 2023
- Watch and Wait, Watchful Waiting, W&W, and Watch and WORRY--what does it all mean? February 5, 2023